BioSpace News Archive

KalGene Pharmaceuticals, Inc. announces a new peer-review publication demonstrating the efficacy of KG207 in clearing toxic oligomer species of amyloid beta in translational imaging studies

KalGene Pharmaceuticals, Inc. announced today a publication of a peer review article Preclinical in vivo longitudinal assessment of KG207-M as a disease-modifying Alzheimer’s disease therapeutic.

August 31, 2021
·
3 min read
Pharm Country

Novartis launches Meet The PROS to raise awareness and support education for PIK3CA-Related Overgrowth Spectrum (PROS)

PROS is a spectrum of at least 13 rare conditions driven by mutations in the PIK3CA gene, typically associated with tissue overgrowth, vascular malformations, and neurological disorders

August 31, 2021
·
8 min read
Biotech Beach

ARS Pharmaceuticals Raises $55 Million in Series D Funding for Launch Preparations of Neffy™ (epinephrine nasal spray)

ARS Pharmaceuticals, Inc. has closed on a Series D financing of $55 million led by SR One with participation from RA Capital Management, and one other U.S.-based, healthcare-focused fund, as well as existing investor, Deerfield Management.

August 31, 2021
·
4 min read
Satellos Bioscience Announces Second Quarter 2021 Financial Results and MD&A

Satellos is developing small molecule drugs that restore faulty regeneration and repair observed in the muscles of patients with Duchenne muscular dystrophy and potentially other degenerative muscle disorders.

August 31, 2021
·
7 min read
Biotech Beach

Avidity Biosciences to Participate in Upcoming Investor Conferences - Aug 31, 2021

Avidity Biosciences, Inc. a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates, announced that the Avidity management team will be participating at the following conferences

August 31, 2021
·
2 min read
CVR Medical Corp. Announces Completion of 2021 2nd Quarter Financial Statement

CVR Medical Corp. is a healthcare company that operates in the medical device industry focused on the commercialization of its disruptive, proprietary Carotid Stenotic Scan device (the “CSS”).

August 31, 2021
·
3 min read
Defence Therapeutics Files Acid-Based Hydrogels USA Provisional Patent Application

Hydrogels are cross-linked polymer networks that can swell and retain a significant amount of water within its structure.

August 31, 2021
·
4 min read
Pharm Country

BioSig Confirmed as a Participant of The Mark E. Josephson Twenty-Eight Annual State-of-the-Art Arrhythmia Virtual Symposium

BioSig Technologies, Inc. today announced that the Company had been invited to participate in The Mark E. Josephson Twenty-Eight Annual State-of-the-Art Arrhythmia Symposium, due to take place virtually on September 11, 2021

August 31, 2021
·
6 min read
PreveCeutical Receives AU$315,338 Research & Development Tax Incentive Cash Refund

The cash refund is related to expenditure on eligible Australian R&D activities conducted during the financial year ended December 31, 2020

August 31, 2021
·
4 min read
Genetown

Jacobio Pharmaceuticals Announces 2021 Interim Results

Jacobio Pharmaceuticals (“Jacobio”, 1167.HK) announced its results for the first half of 2021. Investment in R&D for the clinical-stage biotech firm reached 175 million yuan (approx. US$27 million) for the half year, up 146 percent year-on-year.

August 31, 2021
·
4 min read